Latest Calcineurin Stories
MIT researchers have uncovered “a faulty brain mechanism” they believe is linked to the development of schizophrenia.
Patients who receive kidney transplants must take lifelong medications that, while preventing organ rejection, can also compromise other aspects of health.
LA JOLLA, Calif., June 23 /PRNewswire/ -- CalciMedica announced the appointment of Steven L. Schoenfeld, MD, as Vice President, Clinical Development. Dr. Schoenfeld's successful, clinical drug development career spans over 20 years in the pharmaceutical and biotechnology industries.
Scientists are reporting the first-ever data to show that the enzyme calcineurin is critical in controlling normal development and function of heart cells, and that loss of the protein leads to heart problems and death in genetically modified mice.
LA JOLLA, Calif., Feb. 16 /PRNewswire/ -- CalciMedica today announced that the US Patent and Trademark Office has issued to CalciMedica US Patent No. 7,645,588, a composition patent involving STIM1, a key component of the calcium release-activated calcium (CRAC) channel.
Canadian scientists say they've found the interaction of a specific protein regulates the development of nerve connections in the visual system of tadpoles. The researchers at the Montreal Neurological Institute and Hospital said their findings help clarify how networks of nerve cell connections become
Transplant patients rely on drugs to prevent graft rejection, but at the cost of serious side effects. The class of immunosuppressive drugs known as calcineurin inhibitors
Scientists from A*STAR's Singapore Immunology Network (SIgN) and the University of Milano-Bicocca, Italy, have discovered another signaling pathway for the activation and apoptosis, or programmed cell death, of dendritic cell
A new drug being studied for the treatment of muscle degenerating diseases has shown promising results. According to a study published today in the British Journal of Pharmacology, Debio 025 is as effective as current drugs but, crucially, does not cause unwanted immunosuppressive effects.
Research in mice and human stem cells suggests new therapeutic targets.
- Large; stout; burly.